Kouri, Naomi
Murray, Melissa E.
Reddy, Joseph S.
Serie, Daniel J.
Soto-Beasley, Alexandra
Allen, Mariet
Carrasquillo, Minerva M.
Wang, Xue
Castanedes, Monica Casey
Baker, Matthew C.
Rademakers, Rosa
Uitti, Ryan J.
Graff-Radford, Neill R.
Wszolek, Zbigniew K.
Schellenberg, Gerard D.
Crook, Julia E.
Ertekin-Taner, Nilüfer
Ross, Owen A.
Dickson, Dennis W. http://orcid.org/0000-0001-7189-7917
Funding for this research was provided by:
National Institute of Neurological Disorders and Stroke (UG3 NS104095, U54 NS100693, R01 NS78086, U54 NS100693)
National Institute on Aging (P30 AG062677, R01 AG054449, R01 AG56366)
U.S. Department of Defense (W81XWH-17-1-0249)
Biogen (228PD201)
Biohaven Pharmaceuticals (BHV4157-206, BHV3241-301)
Neuraly (NLY01-PD-1)
National Institutes of Health (P01 AG017586, U54 NS100693, UG3 NS104095)
Article History
Received: 23 November 2020
Revised: 15 February 2021
Accepted: 16 February 2021
First Online: 26 February 2021